Topical 0.02% Mitomycin C for management of primary corneal-conjunctival intraepithelial neoplasia as primary therapy: A long term follow up

Journal Title: International Archives of Integrated Medicine - Year 2016, Vol 3, Issue 8

Abstract

Background: The corneal-conjunctival intraepithelial neoplasia (CCIN) is an ocular surface neoplasia commonly found among populations exposed to strong UV light. Although surgical excision is mainstay treatment, topical Mitomycin-C (MMC) 0.02% has been tried as a sole therapeutic treatment of non- invasive Ocular Surface Squamous Neoplasia (OSSN). Aim: The aim of this study was to report the long term outcome of treatment of non invasive ocular surface squamous neoplasia with topical Mitomycin C (0.02%) as primary therapy. Materials and methods: Total six eyes of six patients with CCIN were treated with topical mitomycin C (0.02%) alone as a sole therapy. All patients received topical MMC (0.02%) four times daily as a cycle therapy of two week ON and two week OFF for 12 weeks. The patients were followed up to two years. Results: All patients showed total cure with no recurrence during 2 years follow up period. Ocular irritation and mild conjunctival hyperemia were observed in 4 eyes during treatment with MMC. There were no serious complications noted at the end of the follow-up period. Conclusion: We concluded that Topical Mitomycin C (0.02%) may be used as a sole therapeutic treatment of non invasive Ocular surface squamous neoplasia with close on going follow-up.

Authors and Affiliations

J. Murli Manoher, Dr. Praveena, Anju Kochar, Anil Chauhan

Keywords

Related Articles

A study of ocular movements and pupillary changes in acute stroke patients

Background: Cerebrovascular disease or stroke rank first in frequency and importance, among all the neurological diseases of adult life. It is the third most common cause of death in the world. Different neuroanatomical...

General versus spinal anesthesia in percutaneous nephrolithotomy: A comparative study

Background: Percutaneous nephrolithotomy (PCNL) is usually done under general anesthesia (GA). However, it can be done under spinal anesthesia (SA) which can have advantages like less bleeding, less postoperative pain, l...

A prospective, randomized controlled study to compare the intubating conditions achieved with suxamethonium and rocuronium bromide

Background: Endotracheal intubation is required for giving general anesthesia for which adequate muscle relaxation is necessary. Suxamethonium is still used as a relaxant for endotracheal intubation Rocuronium, a nondepo...

A lipid profile study amongst the patients of type 2 diabetes mellitus - A cross sectional study

Introduction: India leads the world with largest number of diabetic patients and is often referred to as the diabetes capital. Diabetic dyslipidemia in India is one of the main causes for Coronary Artery Disease (CAD) mo...

Neutral red staining and trypsin treatment to study viability and culture yield of Dermatophytes

Dermatophytosis is common fungal infection of human being. To diagnose dermatophytic infections microscopic examination should be followed by culture which is essential step. Many times fungus may fail to grow on culture...

Download PDF file
  • EP ID EP487570
  • DOI -
  • Views 117
  • Downloads 0

How To Cite

J. Murli Manoher, Dr. Praveena, Anju Kochar, Anil Chauhan (2016). Topical 0.02% Mitomycin C for management of primary corneal-conjunctival intraepithelial neoplasia as primary therapy: A long term follow up. International Archives of Integrated Medicine, 3(8), 16-22. https://europub.co.uk/articles/-A-487570